Application of tumor size modelling and simulations to support the dose selection of BI 907828 for a Phase II study

Oncology

MIDD

Pharmacometrics

PAGE 31 (2023) Abstr 10465

Neldemo I, Sarr C, Friberg LE, Sailer R, Lamar M, Jayadeva G, Pérez-Pitarch A, Busse D